Annual CFF:
$131.09M+$78.09M(+147.31%)Summary
- As of today, STOK annual cash from financing is $131.09 million, with the most recent change of +$78.09 million (+147.31%) on December 31, 2024.
- During the last 3 years, STOK annual cash from financing has risen by +$129.81 million (+10109.81%).
- STOK annual cash from financing is now -12.47% below its all-time high of $149.76 million, reached on December 31, 2019.
Performance
STOK Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
$3.12M+$2.57M(+463.18%)Summary
- As of today, STOK quarterly cash from financing is $3.12 million, with the most recent change of +$2.57 million (+463.18%) on September 30, 2025.
- Over the past year, STOK quarterly cash from financing has dropped by -$5.04 million (-61.76%).
- STOK quarterly cash from financing is now -97.93% below its all-time high of $150.64 million, reached on June 30, 2019.
Performance
STOK Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$5.62M-$5.04M(-47.29%)Summary
- As of today, STOK TTM cash from financing is $5.62 million, with the most recent change of -$5.04 million (-47.29%) on September 30, 2025.
- Over the past year, STOK TTM cash from financing has dropped by -$132.25 million (-95.93%).
- STOK TTM cash from financing is now -96.27% below its all-time high of $150.57 million, reached on June 30, 2019.
Performance
STOK TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
STOK Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +147.3% | -61.8% | -95.9% |
| 3Y3 Years | +10000.0% | +618.9% | -87.9% |
| 5Y5 Years | -12.5% | +202.0% | +213.4% |
STOK Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | >+9999.0% | -97.4% | +7155.8% | -95.9% | at low |
| 5Y | 5-Year | -12.5% | >+9999.0% | -97.4% | +7155.8% | -95.9% | +337.4% |
| All-Time | All-Time | -12.5% | >+9999.0% | -97.9% | +412.0% | -96.3% | +2430.3% |
STOK Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $3.12M(+463.2%) | $5.62M(-47.3%) |
| Jun 2025 | - | $554.00K(-59.7%) | $10.65M(-91.9%) |
| Mar 2025 | - | $1.37M(+141.9%) | $130.75M(-0.3%) |
| Dec 2024 | $131.09M(+147.3%) | $568.00K(-93.0%) | $131.09M(-4.9%) |
| Sep 2024 | - | $8.16M(-93.2%) | $137.87M(+5.8%) |
| Jun 2024 | - | $120.65M(+6926.8%) | $130.27M(+1247.2%) |
| Mar 2024 | - | $1.72M(-76.6%) | $9.67M(-81.8%) |
| Dec 2023 | $53.01M(+14.2%) | $7.34M(+1206.6%) | $53.01M(+16.0%) |
| Sep 2023 | - | $562.00K(+1070.8%) | $45.71M(+0.3%) |
| Jun 2023 | - | $48.00K(-99.9%) | $45.58M(-6.9%) |
| Mar 2023 | - | $45.05M(>+9900.0%) | $48.96M(+5.5%) |
| Dec 2022 | $46.41M(+3514.4%) | $43.00K(-90.1%) | $46.41M(-0.3%) |
| Sep 2022 | - | $434.00K(-87.3%) | $46.54M(+0.1%) |
| Jun 2022 | - | $3.42M(-91.9%) | $46.51M(+7.6%) |
| Mar 2022 | - | $42.51M(>+9900.0%) | $43.24M(+3268.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $1.28M(-98.8%) | $171.00K(-58.1%) | $1.28M(-98.8%) |
| Sep 2021 | - | $408.00K(+156.6%) | $107.80M(-0.6%) |
| Jun 2021 | - | $159.00K(-70.9%) | $108.42M(-0.2%) |
| Mar 2021 | - | $546.00K(-99.5%) | $108.64M(+0.3%) |
| Dec 2020 | $108.11M(-27.8%) | $106.69M(>+9900.0%) | $108.29M(+5942.8%) |
| Sep 2020 | - | $1.03M(+179.9%) | $1.79M(+843.6%) |
| Jun 2020 | - | $369.00K(+86.4%) | -$241.00K(-100.2%) |
| Mar 2020 | - | $198.00K(+3.1%) | $150.03M(+0.2%) |
| Dec 2019 | $149.76M(+29.5%) | $192.00K(+119.2%) | $149.76M(+0.1%) |
| Sep 2019 | - | -$1.00M(-100.7%) | $149.57M(-0.7%) |
| Jun 2019 | - | $150.64M(>+9900.0%) | $150.57M(>+9900.0%) |
| Mar 2019 | - | -$68.00K(-100.5%) | -$68.00K(-100.5%) |
| Dec 2018 | $115.64M(+1835.7%) | - | - |
| Mar 2018 | - | $12.42M | $12.42M |
| Dec 2017 | $5.97M | - | - |
FAQ
- What is Stoke Therapeutics, Inc. annual cash from financing?
- What is the all-time high annual cash from financing for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. annual cash from financing year-on-year change?
- What is Stoke Therapeutics, Inc. quarterly cash from financing?
- What is the all-time high quarterly cash from financing for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. quarterly cash from financing year-on-year change?
- What is Stoke Therapeutics, Inc. TTM cash from financing?
- What is the all-time high TTM cash from financing for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. TTM cash from financing year-on-year change?
What is Stoke Therapeutics, Inc. annual cash from financing?
The current annual cash from financing of STOK is $131.09M
What is the all-time high annual cash from financing for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high annual cash from financing is $149.76M
What is Stoke Therapeutics, Inc. annual cash from financing year-on-year change?
Over the past year, STOK annual cash from financing has changed by +$78.09M (+147.31%)
What is Stoke Therapeutics, Inc. quarterly cash from financing?
The current quarterly cash from financing of STOK is $3.12M
What is the all-time high quarterly cash from financing for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high quarterly cash from financing is $150.64M
What is Stoke Therapeutics, Inc. quarterly cash from financing year-on-year change?
Over the past year, STOK quarterly cash from financing has changed by -$5.04M (-61.76%)
What is Stoke Therapeutics, Inc. TTM cash from financing?
The current TTM cash from financing of STOK is $5.62M
What is the all-time high TTM cash from financing for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high TTM cash from financing is $150.57M
What is Stoke Therapeutics, Inc. TTM cash from financing year-on-year change?
Over the past year, STOK TTM cash from financing has changed by -$132.25M (-95.93%)